West Lafayette, IN, United States of America

Valeriya N Smolenskaya

USPTO Granted Patents = 17 (Patent Applications = 6)

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 33(Granted Patents)

Location History:

Lafayette, IN (US) (2014 - 2017)
West Lafayette, IN (US) (2014 - 2023)

Company Filing History:

4 out of 919

Gilead Sciences, Inc.

patents

3 out of 19

Otsuka America Pharmaceutical, Inc.

Ambit Biosciences Corporation

patents

7. 1 out of 1

Progenics Pharmamceuticals, Inc.

patent

8. 1 out of 67

Progenics Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2014-2023

Loading Chart...

17 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11773098 - Solid forms of a toll-like receptor modulator (2023-10-03),

2. 11299458 - Crystalline compounds (2022-04-12),

3. 10946004 - Solid forms of an ASK1 inhibitor (2021-03-16),

4. 10800740 - Crystalline compounds (2020-10-13),

5. 10508117 - Solid forms of a toll-like receptor modulator (2019-12-17),

6. 10280141 - Crystalline compounds (2019-05-07),

7. 9879024 - Crystal forms of (R)-N-methylnaltrexone bromide and uses thereof (2018-01-30),

8. 9856217 - Crystalline compounds (2018-01-02),

9. 9708261 - Crystalline compounds (2017-07-18),

10. 9643956 - Solid forms of an ASK1 inhibitor (2017-05-09),

11. 9624271 - Romidepsin solid forms and uses thereof (2017-04-18),

12. 9585892 - Solid forms comprising N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith (2017-03-07),

13. 9518094 - Romidepsin solid forms and uses thereof (2016-12-13),

14. 9102680 - Crystal forms of (R)-N-methylnaltrexone bromide and uses thereof (2015-08-11),

15. 8980825 - Romidepsin solid forms and uses thereof (2015-03-17),

Title: The Innovative Mind of Valeriya N. Smolenskaya

Introduction: Valeriya N. Smolenskaya, an accomplished inventor located in West Lafayette, Indiana, has made significant contributions to the field of pharmaceuticals and biotechnology. With an impressive portfolio of 15 patents, she is recognized for her innovative approaches to drug design and formulation.

Latest Patents: Among her latest inventions, Smolenskaya has developed solid forms of a toll-like receptor modulator, providing crystalline forms, solvates, and hydrates of 4-amino-2-butoxy-8-(3-(pyrrolidin-1-ylmethyl)benzyl)-7,8-dihydropteridin-6(5H)-one, along with methods of making them. Furthermore, she has worked on crystalline compounds, specifically relating to (1R,5S)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane hydrochloride, including compositions featuring the same and methods of making and utilizing these compounds.

Career Highlights: Throughout her career, Valeriya has worked with leading companies such as Gilead Sciences, Inc. and Otsuka America Pharmaceutical, Inc. Her experience in these prestigious organizations has allowed her to hone her skills and contribute to significant advancements in medicinal chemistry.

Collaborations: Smolenskaya has collaborated with notable colleagues such as David Alan Engers and Anthony Alexander McKinney. These partnerships have played a key role in fostering innovation and facilitating the development of groundbreaking pharmaceutical solutions.

Conclusion: Valeriya N. Smolenskaya stands out as a prominent figure in the realm of invention and innovation. Her dedication to advancing pharmaceutical sciences and her successful patent portfolio underscore her vital role in the industry. As she continues to push the boundaries of scientific knowledge, her contributions will undoubtedly inspire future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.